I-MAB SPONS.ADS/1 -0001 (0VY) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.063x

Based on the latest financial reports, I-MAB SPONS.ADS/1 -0001 (0VY) has a cash flow conversion efficiency ratio of -0.063x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-14.60 Million ≈ $-17.06 Million USD) by net assets (€230.94 Million ≈ $269.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 0VY market cap overview for the company's overall valuation and market capitalisation.

I-MAB SPONS.ADS/1 -0001 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how I-MAB SPONS.ADS/1 -0001's cash flow conversion efficiency has evolved over time, based on yearly financial data.

I-MAB SPONS.ADS/1 -0001 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of I-MAB SPONS.ADS/1 -0001 ranked by their cash flow conversion efficiency. See I-MAB SPONS.ADS/1 -0001 cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
CB Financial Services Inc NASDAQ:CBFV	0.046x
Electreon Wireless Ltd TA:ELWS	-0.134x
Guangdong Electric Power Devel SHE:200539	0.060x
Ames National Corporation NASDAQ:ATLO	0.013x
HARIM Co. Ltd KQ:136480	0.021x
Lindsay Australia Ltd AU:LAU	0.282x
Tatung System Technologies TWO:8099	-0.035x
Inversora Juramento SA BA:INVJ	-0.033x

Annual Cash Flow Conversion Efficiency for I-MAB SPONS.ADS/1 -0001 (2021–2025)

The table below shows the annual cash flow conversion efficiency of I-MAB SPONS.ADS/1 -0001 from 2021 to 2025. View 0VY stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€230.94 Million ≈ $269.99 Million	€-20.60 Million ≈ $-24.08 Million	-0.089x	+65.94%
2024-12-31	€201.16 Million ≈ $235.18 Million	€-52.67 Million ≈ $-61.58 Million	-0.262x	+12.63%
2023-12-31	€242.58 Million ≈ $283.61 Million	€-72.70 Million ≈ $-84.99 Million	-0.300x	-154.92%
2022-12-31	€421.77 Million ≈ $493.09 Million	€-49.58 Million ≈ $-57.97 Million	-0.118x	+44.92%
2021-12-31	€715.33 Million ≈ $836.29 Million	€-152.66 Million ≈ $-178.48 Million	-0.213x	--

About I-MAB SPONS.ADS/1 -0001

F:0VY Germany Biotechnology

Market Cap

$189.29 Million

€161.91 Million EUR

Market Cap Rank

#16850 Global

#1587 in Germany

Share Price

€1.40

Change (1 day)

+2.94%

52-Week Range

€1.25 - €5.60

All Time High

€70.00